Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Ono Enters into Agreement with Seikagaku for Joint Development and Marketing of Gel-One
Friday, August 08, 2025Ono Pharmaceutical and Seikagaku have finalised an agreement to jointly develop and market GelOne a treatment for osteoarthritis in Japan
Astria Therapeutics Enters into Agreement with Kaken Pharmaceutical to Develop and Commercialise Navenibart for HAE Treatment
Thursday, August 07, 2025Astria Therapeutics has entered into an exclusive licensing agreement with Kaken Pharmaceutical to develop and commercialise navenibart for hereditary angioedema HAE in Japan
Jazz Pharmaceuticals Receives Approval for Modeyso™ to Treat Recurrent H3 K27M-Mutant Diffuse Midline Glioma
Thursday, August 07, 2025Jazz Pharmaceuticals has announced that the US Food and Drug Administration FDA has granted accelerated approval for Modeyso dordaviprone
SERB Pharmaceuticals to Acquire Y-mAbs Therapeutics in $412 Million
Wednesday, August 06, 2025SERB Pharmaceuticals has announced the acquisition of YmAbs Therapeutics The agreement values YmAbs at approximately million in an allcash transaction
Porosome Therapeutics Unveils Breakthrough Discoveries in Alzheimer’s Research
Wednesday, August 06, 2025Porosome Therapeutics has announced major developments in its neurological treatment platform aimed at tackling the root causes of Alzheimers disease ADThe companys innovative approach offers a potential shift in AD treatment by focusing on disease m...
Axplora Invests €6.5 Million to Expand Vizag Site and Achieves FDA Success Across Indian Operations
Wednesday, August 06, 2025Axplora has announced a million investment to expand its Vizag site in IndiaThe move aims to increase production capacity and strengthen the companys global supply chain
MetaVia and Syntekabio Partner to Explore New Indications for DA-1241 Using AI Technology
Wednesday, August 06, 2025MetaVia has announced a research partnership with Syntekabio to explore additional therapeutic uses for DA its investigational oral drug targeting GProteinCoupled Receptor GPR
Bristol Myers Squibb’s Breyanzi Accepted for Priority Review by FDA for Marginal Zone Lymphoma
Tuesday, August 05, 2025Bristol Myers Squibb has announced that the US Food and Drug Administration FDA has accepted the supplemental biologics licence application sBLA for Breyanzi lisocabtagene maraleucel lisocel
Innovent Receives Approval for IND Application of Oral GLP-1R Agonist IBI3032
Tuesday, August 05, 2025Innovent Biologics has received approval from the United States Food and Drug Administration FDA for its investigational new drug IND application to begin Phase clinical trials of IBI an oral GLP receptor agonist
WuXi XDC’s DP3 Facility at Wuxi Site Gains GMP Approval, Expands Manufacturing Capacity
Tuesday, August 05, 2025WuXi XDC has announced the GMP release of its newly launched Drug Product DP facility at the Wuxi site completed at the end of July
